Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania

被引：61
作者：
Moyo S.J. [1 ]
Aboud S. [1 ]
Kasubi M. [2 ]
Lyamuya E.F. [1 ]
Maselle S.Y. [1 ]
机构：
[1] Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam
[2] Department of Laboratory Services-Central Pathology Laboratory, Muhimbili National Hospital, Dar es Salaam
来源：
BMC Research Notes | / 3卷 / 1期
关键词：
Urinary Tract Infection; Cefotaxime; Ceftazidime; Imipenem; Nalidixic Acid;
D O I：
10.1186/1756-0500-3-348
中图分类号：
学科分类号：
摘要：
Background. Published data on the existence and magnitude of extended spectrum beta-lactamase (ESBL) production in urinary pathogens in local setting is limited. The aim of the present study was to determine the prevalence of antimicrobial resistance and ESBL production among Escherichia coli and Klebsiella spp from urine samples in a tertiary hospital. This was a cross sectional study conducted at Muhimbili National Hospital in Dar es Salaam, Tanzania. Findings. A total of 270 E.coli and Klebsiella spp urinary pathogens from children and adults isolated from January to March 2010 were included in the study. E. coli and Klebsiella spp isolates were tested for antimicrobial susceptibility by the Clinical and Laboratory Standard Institute's disc diffusion method. These isolates were further screened for ESBL phenotype using cefotaxime and ceftazidime discs. Isolates with reduced sensitivity were confirmed using ESBL E-test strips. Of 270 isolates, 138 (51.1%) were E. coli and 132 (48.9%) were Klebsiella spp. ESBL was detected in 122 (45.2%) of all the isolates. ESBL- producing E. coli strains were significantly more resistance to cotrimoxazole (90.7%), ciprofloxacin (46.3%) and nalidixic acid (61.6%) than strains that did not produce ESBL (p < 0.05). Similarly, ESBL- producing Klebsiella spp strains were significantly more resistance to cotrimoxazole (92.6%), ciprofloxacin (25.0%), nalidixic acid (66.2%), and gentamicin (38.2%) than strains that did not produce ESBL (P < 0.05). Multi-drug resistance was found to be significantly (P < 0.05) more in ESBL producing isolates (90.5%) than non ESBL producers (68.9%). The occurrence of ESBL was significantly higher among isolates from inpatients than outpatients [95 (50.5%) vs. 27(32.9%)] (p = 0.008). The occurrence of ESBL was significantly higher among isolates from children than in adults [84 (54.9%) vs. 38(32.5%)] (p < 0.001). Conclusions. High prevalence of ESBL-producing E. coli and Klebsiella spp strains was found among inpatients and children. Most of the ESBL- producing isolates were multi-drug resistant making available therapeutic choices limited. We recommend continued antibiotic surveillance as well comprehensive multi-center studies to address the emerging problem of ESBL-associated infections in order to preserve the continued usefulness of most antimicrobial drugs. Further more conducting molecular studies will help to evaluate the various ESBL types. © 2010 Moyo et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 23 条
[1]  
Gonzalez C.M., Schaeffer A.J., Treatment of urinary tract infection: What's old, what's new, and what works, World J Urol, 17, pp. 372-382, (1999)
[2]  
Stamm W.E., Stapleton A.E., Approach to the patient with urinary tract infection, Infectious Diseases, pp. 1270-1272, (1998)
[3]  
Gupta K., Sahm D.F., Mayfield D., Stamm W.E., Antimicrobial resistance among uropathogens that cause community acquired urinary tract infections in women. A nationwide analysis, Clin Infect Dis, 33, pp. 89-94, (2001)
[4]  
Gales A.C., Jones R.N., Gordon K.A., Sader H.S., Wilke W.W., Beach M.L., Pfaller M.A., Doern G.V., Activity and spectrum of 22 antimicrobial agents tested against urinary tract pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998), J Antimicrob Chemother, 45, pp. 295-303, (2000)
[5]  
Tankhiwale S.S., Jalgaonkar S.V., Ahamad S., Hassani U., Evaluation of extended spectrum beta lactamase in urinary isolates, Indian J Med Res, 120, pp. 553-556, (2004)
[6]  
Mohammed A., Mohammed S., Asad U.K., Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India, Ann Clin Microbiol Antimicrob, 6, (2007)
[7]  
Steinke D.T., Seaton R.A., Phillips G., MacDonald T.M., Davey P.G., Prior trimethoprim use and trimethoprim-resistant urinary tract infection: A nested case-control study with multivariate analysis for other risk factors, J Antimicrob Chemother, 47, pp. 781-787, (2001)
[8]  
Black J.A., Moland E.S., Thomson K.S., AmpC disk test for detection of plasmid-mediated AmpC-b lactamases in Enterobacteriaceae lacking chromosomal AmpC-b lactamases, J Clin Microbiol, 43, pp. 3110-3113, (2005)
[9]  
Manges A.R., Natarajan P., Solberg O.D., Dietrich P.S., Riley L.W., The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: Evidence for community outbreaks of urinary tract infections, Epidemiol Infect, 134, pp. 425-431, (2006)
[10]  
Blomberg B., Jureen R., Manji K.P., Tamim B.S., Mwakagile D.S., Urassa W.K., Fataki M., Msangi V., Tellevik M.G., Maselle S.Y., Langeland N., High rate of fatal cases of pediatric caused by gram-negative bacteria with extended-spectrum betalactamases in Dar es Salaam, Tanzania, J Clin Microbiol, 43, pp. 745-749, (2005)
123